InsidersTradesSigma
Follow the 幸康 stock price and the full directors' dealings record of the company, a publicly traded company based in Taiwan. Shares trade on TW TW, under the authority of TWSE / TPEx (MOPS). Market capitalisation: €3.1bn. The latest transaction was reported on 27 April 2026 (Gift). Among the most active insiders: 呂惠清. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
幸康 is a company listed on the XTAI market, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance patient well-being.